KKR Inks Agreement To Sell 10% Stake In Nordic Bioscience To Its Founder Claus Christiansen; Financial Terms Undisclosed

Benzinga Newsdesk www.benzinga.com Neutral 93.2%

Neg 0% Neu 93.2% Pos 0%

https://media.kkr.com/news-details?news_id=c24c0635-296f-415c-bd35-c2200bf970e6

Comments

No comments yet. Be the first!